Background-Although cardiac magnetic resonance imaging (CMR) is capable of yielding extensive data in routine practice, the relative incremental prognostic value of adenosine stress perfusion, myocardial delayed enhancement (DE), and left ventricular volumes and function is unclear. Methods and Results-We followed up 908 consecutive patients who underwent combined CMR for suspicion of coronary stenosis and/or ischemia at 2.6Ϯ1.2 years, during which 101 total cardiac events occurred (all-cause death, myocardial infarction, or late revascularization). Increase in Cox proportional-hazards model global 2 ( 2 ) with the addition of CMR data after adjustment for clinical data defined incremental prognostic value. Cardiac magnetic resonance imaging without abnormalities had a 2.4% event rate per year (Ͻ1% cardiac death or myocardial infarction). Abnormal CMR was associated with event rates of 5.6% to 7.0% per year, varying with which and how many components were abnormal. After adjusting for the pre-CMR data (age, dyspnea, prior coronary artery disease, resting heart rate, renal disease, and diabetes mellitus, 2 :43.6, PϽ0.0001; C index 0.695), the addition of left ventricular ejection fraction, aortic flow, delayed enhancement, and stress perfusion data all incrementally increased 2 (55.2, 63.3, 68.0, and 68.9, respectively; all PϽ0.00001; C indices 0.717, 0.722, 0.747, and 0.736). The number of abnormal CMR domains both added incremental prognostic value and risk stratified patients with respect to risk of events. Conclusions-CMR analysis of ventricular volume, aortic flow, myocardial viability, and stress perfusion all add incremental value for prediction of adverse events over pre-CMR data and can be combined to further enhance prognostication. Normal combined CMR confers a low risk of subsequent cardiac events. (Circulation. 2011;123:1509-1518.) 
T he worsening healthcare crisis has increased pressures to limit the use of expensive imaging modalities. 1 These issues have been exacerbated by the rapid expansion of the imaging armamentarium used for the assessment of patients with known or suspected coronary artery disease (CAD). This has resulted in pressures to more thoroughly evaluate new and emerging technologies before their clinical acceptance and reimbursement, possibly requiring the development of a body of evidence to support their use.
Clinical Perspective on p 1518
Prognostic assessment plays a central role in the evaluation and management of patients with known or suspected CAD. Various noninvasive cardiac imaging modalities that are designed to assess myocardial perfusion or ventricular wall motion have demonstrated incremental prognostic power compared with clinical risk assessment. [2] [3] [4] [5] [6] [7] Of the newer modalities currently in use, cardiac magnetic resonance imaging (CMR) uniquely provides detailed diagnostic information on myocardial viability, vasodilator stress perfusion, ventricular wall motion and volumes, cardiac output, and valvular abnormalities. 8 Although stress CMR protocols often assess and report all of these parameters, previous studies have focused on the incremental prognostic value of 1 or 2 parameters. The relative incremental predictive value of the combination of all of these component indices of CMR for future cardiac events is unknown. The objective of the current study was to assess the incremental prognostic power of myocardial viability, vasodilator stress perfusion, and ventricular wall motion and volumes over patient clinical and historical data alone for the prediction of adverse cardiac events.
Methods
The current study is intended to be an effectiveness study (ie, a study in which referring physicians rather than the study design dictate the selection of patients for testing and the nature of post-CMR patient management).
Study Population
All patients referred to stress CMR at Central Utah Clinic (Provo, UT) between July 7, 2002, and October 31, 2006 (inclusive) , were prospectively enrolled in a preplanned and predefined data registry. Informed consent was obtained at the time of testing, and all patient information was collected and protected in compliance with the Health Insurance Portability and Accountability Act standards under investigational review board approval. We identified 1009 patients who were referred for stress CMR and underwent a protocol combining 4 components: adenosine stress perfusion, myocardial delayed enhancement, left ventricular volumes and function, and aortic blood flow CMR in an outpatient clinic setting. As shown in Figure 1 ,7 patients who were initially referred for stress CMR began, but did not complete, imaging because of claustrophobia and were excluded from analyses. Following American College of Cardiology/ American Heart Association definitions, 9 70 patients had moderate to severe valvular disease and were excluded from analysis. No patients were excluded for uninterpretable images. Successful follow-up was completed in 97.6% of these patients, leaving a final study population of 908 patients who were followed up for a median of 948 days (25th, 75th percentiles: 639, 1263).
CMR Image Acquisition
After informed consent, adenosine was infused via a peripheral vein for at least 2 minutes and 45 seconds and was discontinued only after left ventricular myocardial contrast arrival was visualized. The stress gadoversetamide dosage used was 0.1 mmol/Kg given at 3 cc/s. Adenosine infusion was discontinued when left ventricular myocardial contrast arrival was noted. An ECG-triggered, interleaved, notched saturation gradient echo sequence was performed with an 8-channel cardiac receiver coil, array spatial and sensitivity technique (order 2) on a 1.5T magnet (Twinspeed Zoom Mode, General Electric Medical Systems, Milwaukee, WI). Subsequently, 5 to 10 short-axis left ventricular slices (dependent on heart rate) were obtained over every other cardiac cycle during the first pass of contrast in the left ventricle. In all, 40 stress perfusion images were acquired for every slice over 80 cardiac cycles. Immediately after stress first-pass perfusion imaging, a second dose of gadoversetamide 0.1 mmol/Kg was given (total 0.2 mmol/Kg). Late gadolinium enhancement imaging was begun 10 minutes later. Myocardial delayed enhancement (DE) imaging was performed using a segmented k-space inversion recovery sequence with optimized inversion time. All patients underwent cine functional imaging using a steady state free-precession sequence acquiring a short-axis stack through the entire heart with typical spatial resolution of at least 2.0ϫ2.6ϫ8.0 mm using retrospective ECG gating. Breath-hold segmented k-space velocity-encoded phase contrast imaging was performed perpendicular to the proximal ascending aorta using retrospective ECG gating and phantom correction of background phase offsets.
CMR Image Analysis and Interpretation
Image postprocessing and analysis were performed on a dedicated workstation using ReportCard version 3.7 (General Electric Medical Systems, Milwaukee, WI). Left ventricular end-diastolic and endsystolic frames were identified in the short-axis stack. Left ventricular contours were drawn to include the papillary muscles as part of the blood pool. The extent of myocardial late enhancement was expressed as quintiles of transmurality (normalϭ0, 1% to 25%, 26% to 50%, 51% to 75%, and 76% to 100%) for each of the 17 left ventricular segments by visual analysis. Stress perfusion defect was defined by visual analysis. Perfusion defects were considered abnormal if all of the following were observed: (1) The defect was subendocardial or transmural, (2) was present in at least 2 contiguous short-axis slices, (3) persisted at least 10 seconds after first myocardial contrast arrival, and (4) conformed to a coronary artery territory. Isolated epicardial or papillary muscle defects and susceptibility artifacts were considered nonischemic. Rest perfusion imaging was not performed. Stress perfusion defect was expressed in 3 categories (normal, subendocardial, or transmural) for each of the 16 left ventricular short-axis segments (perfusion imaging was not performed in the long axis). A composite CMR end point combining information from left ventricular function (left ventricular ejection fraction [LVEF] normal versus abnormal), DE (present versus absent), and stress perfusion (normal versus abnormal) was set equal to the number of these elements abnormal (minimum: 0, maximum: 3). Aortic blood flow was measured by phase-contrast velocity encoding perpendicular to the proximal aorta above the coronary artery ostia. Phantom correction for background velocity offsets was performed in all cases. Offline ventricular volume measurements were made by the Simpson method. All measurements conform to accepted cardiac imaging standards. 10 LVEF Ͻ50% was considered abnormal.
Patient Follow-Up and Outcome Measures
All patients were followed up for a minimum of 1 year after their index CMR study (mean follow-up 2.6Ϯ1.2 years). Outcomes were identified by a review of hospital and outpatient electronic medical records, a mail questionnaire completed by study subjects, and a prescripted telephone interview with each study subject.
The primary end point of this study was the occurrence of cardiac events, defined as the aggregate of all-cause death, nonfatal myocardial infarction, or late (Ͼ90 days postindex test) revascularization. To better understand the ability of normal CMR results to identify low risk, secondary end points were used solely for analyses of normal CMR results. These included cardiac death and hard events (cardiac death or myocardial infarction [MI]). In patients with multiple events, only the first event was considered for survival analysis. Event rates were annualized by dividing the observed events by the mean duration of follow-up for each group. Valve surgery without revascularization was not considered an event.
Statistical Analysis
Baseline patient characteristics were described in terms of median (25 th and 75th percentiles) for continuous variables and frequencies for categorical variables. Categorical variables were compared using a 2 test. A Bonferroni correction was used to correct for multiple comparisons. A 2-tailed value of PϽ0.05 was considered statistically significant.
Multivariable Modeling and Survival Analysis
Cox proportional hazards modeling was used to assess the association of CMR information and survival time free of cardiac events after adjusting for other potential confounders. [11] [12] [13] Because both the inclusion and exclusion (censoring) of patients undergoing early revascularization introduces biases that may distort our results, all survival models were stratified by the use of early revascularization. 12 The association of referral to early revascularization and clinical, historical, and testing data were modeled using multiple logistic regression. 12, 13 Covariate selection for model entry was based on clinical experience and identification of known confounders. The models were carefully examined, when applicable, for proportional hazards assumption, multicollinearity, and the additive value of the terms. 12 A ratio of Ͼ10 events per degree of freedom of the model was maintained.
The event-free survival stratified by key CMR parameters was plotted using the Kaplan-Meier method, and was compared using log-rank tests. The S-PLUS 2000 (Release 2) software package (Insightful Corp, Seattle, WA) with supplemental libraries (Hmisc, Design) was used for all analyses.
Determination of Incremental Value
Incremental prognostic value was defined as a significant increase in the Wald statistic and likelihood ratio tests after the addition of imaging data to an optimized Cox model of preimaging data alone. We performed 2 sets of analyses. First, on the basis of pre-CMR data, we developed a model predicting the study end point. Second, we added the results of pre-Gadolinium CMR data (LV volumes, LVEF, valvular data) to the first model (because these data elements are often known before testing and, if not, could be defined without proceeding with additional testing). Third, we added DE data to the model from the previous, second step. In a parallel third step to this, we evaluated the added value of stress perfusion data over the second model as well (because DE and stress perfusion could either be obtained independently of the other). Finally, we considered information from all CMR data combined.
Incremental prognostic value was considered to be present for any of these steps when a significant increase in Wald global 2 was found. On the basis of these Cox proportional hazards models, risk-adjusted survival curves were developed. Regression models were validated by means of resampling (100 iterations), and biascorrected C indices were determined. Model calibration was assessed by constructing a bootstrap-corrected calibration curve by resampling the differences between average Cox proportional hazards predicted survival and Kaplan-Meier (observed) estimates at a single time point.
Reclassification
The impact of CMR results on reclassification of patient risk was determined using net reclassification improvement (NRI). 14 For each patient, the predicted risk of an adverse event was determined on the basis of each model, and we then assessed the impact on patient reclassification of the addition of information to these models. Reclassification to a higher-risk group was considered upward movement in classification, whereas reclassification to a lower-risk group was considered downward movement. Improvement in reclassification was estimated by taking the sum of differences in proportions of individuals reclassified upward minus the proportion reclassified downward for people who developed events and the proportion of individuals moving downward minus the proportion moving upward for those who did not develop events. NRI represents the net number of patients with improved reclassification, summing reclassification in patients with events and patients without events.
Because there are no accepted thresholds defining low versus intermediate-to-high risk for total events, we examined reclassification using thresholds of 1.5% and 2.0% total events per year to define low-, intermediate-, and high-risk groups.
Results

Patient Characteristics and CMR Findings
Patients in this study tended to be middle-aged and predominantly male, with the majority having known hypertension, a smaller number with a family history of premature CAD, and about a quarter with diabetes mellitus (Table 1) . About half of patients presented with dyspnea and /or angina, but of the latter, Ͻ10% had typical angina at the time of presentation. Relatively small numbers of patients had significant comorbidities, and about half had a history of prior CAD. Of the latter, about one third had prior MI or percutaneous coronary intervention (PCI), and smaller numbers had coronary artery bypass grafting (CABG). About one third of patients had abnormal stress perfusion or delayed enhancement, and 44% had abnormal wall motion. Additionally, 276 patients had subendocardial segmental defects whereas 53 had transmural segmental defects. Transmural defects occurred more frequently among patients with versus without prior MI (12.3% versus 2.4%, respectively; PϽ0.001). 
Patient Outcomes
During the follow-up period, we identified 101 cardiac events (9.8%; death, MI, or late revascularization). These included 30 cardiac deaths, 36 noncardiac deaths, 5 nonfatal MIs, and 19 late revascularizations. These late revascularizations included 13 late PCI and 9 late CABG (3 patients underwent both PCI and CABG on follow-up, and were thus counted only once for late revascularization). In addition, 103 patients underwent revascularization (91 PCI, 13 CABG) early (Ͻ90 days) after the index CMR study.
CMR Results and Referral to Early Revascularization
Referral to early revascularization after CMR increased as a function of both DE and stress perfusion results ( Figure 2 ). Although revascularization rates were greater with abnormal compared to normal DE (20.5% versus 5.8%), they were also greater after abnormal compared with normal stress perfusion both in the setting of normal and abnormal DE. Further, revascularization rates were also greater with abnormal than with normal DE in the setting of normal perfusion (11.2% versus 3.5%). Logistic regression modeling of early revascularization ( 2 102, PϽ0.001) revealed that abnormal perfusion and DE were the most closely associated with early revascularization. With respect to the temporal distribution of early revascularizations, 87% occurred in the first 30 days, with 4.1 and 2.0% occurring between 30 to 60 days and 60 to 90 days, respectively. With respect to later revascularizations, 6.7% of them occurred between 90 days and 6 months, and the observed frequency of revascularizations increased after this time point, with 28%, 37%, and 28% occurring between 6 months and 1 year, between 1 and 2 years, and Ͼ2 years after testing.
Univariable Predictors of Adverse Events
Of baseline patient data, the variables most associated with cardiac events included patient age, hypertension, dyspnea, diabetes mellitus, Framingham risk score, and renal disease. Interestingly, prior CAD, PCI, or CABG were not predictors. Rest heart rate was a significant predictor of outcomes (Tables 2 and 3). CMR-defined LVEF and LV stroke volume were predictive of cardiac events. CMR-determined aortic flow was also predictive of cardiac events, as were abnormal wall motion, perfusion, and delayed enhancement, as well as summed scores of these variables.
Event Rates as a Function of CMR Results
Normal CMR results were associated with low risk irrespective of which component was examined ( Figure 3 ). With respect to cardiac death rates, event rates were very low (0.6% to 0.7%), with the exception of postnormal EF, which was slightly higher (1.0%). With respect to hard events, (cardiac death or MI), event rates were low (0.6% to 0.9%) again, with the exception of postnormal EF (1.2%). A similar pattern was present with respect to cardiac events.
Event rates after abnormal CMR results reveal similar cardiac event rates after abnormal DE, EF, or stress perfusion (5.6% to 6.1%). Event rates were greater in the setting of 2 abnormalities (6.5% to 7.0%). With increasing numbers of CMR components found abnormal, risk of adverse outcomes increased significantly (Figure 4; PϽ0.001) . Interestingly, subendocardial perfusion defects were associated with greater risk than transmural perfusion defects, with the former a 
Multivariable Modeling and Survival Analysis
We initially examined the association of pre-CMR data with cardiac events using a Cox proportional hazards analysis, thus identifying a pre-CMR chronic pulmonary hypertension model (model 1). The second model consisted of fixing these covariates and adding LVEF. This resulted in the addition of LVEF into the model with an increase in 2 (global 2 41.7 to 51.5; C index 0.695 to 0.717). Fixing the pre-CMR and LVEF data in the model and adding aortic flow data resulted in an additional increase in global 2 (57.5; C index 0.722; model 3), which was further increased with the addition of DE information ( 2 63.5; C index 0.747; model 4). Finally, the addition of stress perfusion data to pre-CMR data, LVEF, and aortic flow added further value (global 2 62.5; C index 0.740; model 5) ( Table 4 ).
Because of potential bias introduced by patients referred to revascularization early after testing, we also repeated models 4 and 5 using early revascularization as a time-dependent covariate. In model 4, time to early revascularization but not early revascularization or the interaction between these covariates was significant (Pϭ0.0002, Pϭ0.2995, and 0.122, respectively). Similar results were present for model 5 using early revascularization as a time-dependent covariate (early revascularization, time to early revascularization, and the interaction between these covariates were significant: Pϭ0.3084, Pϭ0.0003, and Pϭ0.1462, respectively).
The final modeling step (addition of both DE and stress perfusion data) resulted in a further increase in value ( 2 69.1; C index 0.727), but neither of these variables were significant at a PϽ0.05 level. We believe that this was due to the presence of significant collinearity between the stress perfusion and DE covariates (correlation rϭ0.66, PϽ0.01). This was reflected by both DE and stress perfusion covariates being nonsignificant when both were included in the Cox model. To overcome this, we used the derived composite CMR end point previously defined. After adjusting for the pre-CMR data, the addition of composite CMR end point resulted in a significant increase in 2 (41.7 to 54.1, PϽ0.0001, C index 0.734). Risk-adjusted survival curves reveal significant stratification by the number of CMR components abnormal ( Figure 5 ). In the absence of abnormalities, risk of cardiac events is relatively low; with all 3 components abnormal, adjusted risk is Ϸ30% at about 4 years.
The final modeling step was also performed using extended Cox proportional hazards models, with early revascularization handled using a time-dependent covariable. This approach resulted in a marked decrease of the ␤ of delayed late enhancement from 0.7419 to 0.6275 (Ϸ15.5% decrease; HR 2.10 to 1.87, Table 4 , model 4). With respect to the model including stress perfusion (Table 4 , model 5, last column), no meaningful change in the ␤ for stress perfusion occurred (0.5653 to 0.5437, Ͻ4% decrease, HR 1.76 to 1.72). Finally, graphic presentation of model calibration (observed versus predicted survival) is shown in Figure 6 . Predicted event rates appear to approximate observed event rates through most of the range of values.
Risk Reclassification
Reclassification of risk (classification groups were set at 0 to 1.5%, 1.5% to 2.0%, and Ͼ2.0%) was assessed separately for the addition of DE and stress perfusion data to pre-DE and prestress perfusion data (model 4 to model 3 and model 5 to model 3, respectively; online-only Data Supplement Table I ). The addition of DE data to the pre-DE model resulted in 2 correct (up) reclassifications and 4 incorrect (down) reclassifications in patients who experienced events (NRI events , Ϫ0.022). Additionally, 18 incorrect (up) reclassifications and 109 correct (down) reclassifications occurred in patients who did not have events (NRI nonevents , 0.111). Overall, 8.9% of patients were correctly reclassified by the addition of the delayed enhancement information (NRI net , 0.089).
The addition of stress perfusion data to the model of preimaging data resulted in no correct (up) reclassifications and 2 incorrect (down) reclassifications in patients who experienced events (NRI events , Ϫ0.023). Additionally, 22 incorrect (up) reclassifications and 71 correct (down) reclassifications occurred in patients who did not have events (NRI nonevents , 0.058). Overall, 3.5% of patients were correctly reclassified by the addition of the stress perfusion information (NRI net , 0.035).
Discussion
In the current study, we found that in a series of 908 patients with short-to intermediate-term follow up after index 4 component CMR (assessment of stress perfusion, viability, cardiac flow, and LV structure and function), the CMR results added incremental prognostic information over pre-CMR data and were incremental over each other as well. Hence, they provided complementary rather than overlapping information. After normal combined (4 component) CMR, patients had a low risk of future adverse events and cardiac death (Յ0.4% annual cardiac mortality rate). Conversely, even with a single CMR-defined abnormality (eg, low aortic flow or increased LV end-systolic volume index), patients were found to be at increased risk. Further, additional abnormal findings identified by CMR incrementally increased risk, thus enhancing stratification. On the basis of results of Cox proportional hazards modeling, after adjusting for pre-CMR data, all components of the stress CMR (stress perfusion, DE, and LV function) were incremental over the pre-CMR data as well as over each other. When modeling total events, we found CMR-derived measures of LV volume (LV end-systolic volume index), and hemodynamics (aortic flow) added incremental prognostic value over pre-CMR data, and both stress perfusion and DE added further information over the combination of pre-CMR and pre-stress test CMR data.
Comparison With Previous Studies
The current study extends the results of a number of previous CMR prognostic studies in stable patients with known or suspected CAD. Jahnke et al 5 followed up 302 patients after normal stress CMR perfusion and reported a low event rate comparable to that previously reported with nuclear and echocardiographic techniques. 4 Subsequently, Pilz et al 6 extended these results in a study of 218 patients with normal CMR, reporting similar results. However, not all studies are concordant on this point. 7 Although several studies reported outcomes in patients with normal versus abnormal stress perfusion CMR, with respect to incremental prognostic value, Steel et al 7 recently reported the additive prognostic value of DE and stress perfusion data over pre-CMR data and each other. The results of our study are consistent with previous reports indicating that the presence and extent of myocardial delayed enhancement provides incremental prognostic value for adverse events. 7, [15] [16] [17] [18] The current study extends the findings of previous articles by also examining the third component of the stress examination, resting LV function. In the current study, a number of these CMR parameters added incrementally to each other. Additionally, to the best of our knowledge, the current study is the largest prognostic stress CMR study reported to date.
The presence of abnormalities in stress perfusion, DE, LVEF, and aortic flow each conferred incremental prognostic power to predict future adverse cardiovascular events, and were additive, not redundant, in predicting risk. Similar to nuclear and echocardiographic techniques, stress CMR provides estimates of ischemic burden, myocardial scar/viability, and LV volumes and function. The current study confirms the results of previous studies using these other modalities, that these parameters are prognostically complementary rather than redundant. 4,19 -21 Cardiac magnetic resonance imaging is unique, however, in encompassing the advantages of both of these more widely used techniques. Like echocardiography, CMR can provide assessments of hemodynamics, ventricular structure and function, and vascular and valvular structure. Moreover, CMR, like nuclear techniques, can visualize perfusion abnormalities and discern areas of scar, ischemia, and normal myocardium. Finally, because of its greater temporal and spatial resolution, CMR may have advantages over these other modalities, but its comparative cost effectiveness is uncertain.
Which Is the Most Predictive CMR Variable?
Historically, the 2 associated with individual covariates in the Cox model has been put forward as the metric to compare covariate value. However, because this represents a measure of association, not of effect, the HR would serve as a clinically more relevant measure (although this is not always the case). Thus, the presence of DE is associated with more than a doubling of risk (Table 4 , model 4). LVEF would need to decrease by Ͼ20% to be associated with the same level of risk. Thus, DE would appear to be a superior prognosticator than LVEF. Similar results can be found with stress perfusion compared to LVEF. As discussed above, a delayed enhancement-stress perfusion comparison is challenging because of collinearity, and additional analyses would be required to sort out this comparison.
Risk Reclassification
Analysis of reclassification of risk was performed using the relatively new approach of calculating NRI and number of patients correctly reclassified. 14 The results of this analysis revealed a relatively low NRI and a moderate proportion of patients correctly reclassified. These results are limited because of several issues, including relatively short follow-up, the lack of an accepted threshold for total events (the end point used in the current study), as well as the intrinsic limitations of this approach.
Post-CMR Patient Management
We found that post-CMR revascularization referral is driven predominantly by CMR results. Specifically, the likelihood of referral is largely determined by the presence of ischemia and, to a lesser degree, scar, but not LVEF. In the setting of abnormal ischemia, physicians referred patients to revascularization in similar numbers whether or not DE was present. In the absence of ischemia, a greater revascularization rate was present with versus without DE. The role of ischemia in influencing revascularization decisions is similar to that previously reported with other stress imaging techniques whereas a role for both scar and LVEF has been reported. 4 This close relationship between CMR results and revascularization may have introduced a bias that would obfuscate the relationship between test results and subsequent patient risk because of the influence of revascularization in reducing post-CMR events. This would be consistent with previous publications using other modalities reporting this phenomenon. 12 To overcome this potential bias, rather than censoring patients referred to early revascularization, we retained them in our analyses but used them as a stratification factor in the survival modeling. However, to further examine this issue, we also evaluated extended Cox proportional hazards models using early revascularization as a time-dependent covariate. Finally, with respect to the temporal distribution of post-CMR revascularization, we found that revascularizations aggregated very early (Ͻ30 days) after testing or Ͼ6 months after testing.
Study Limitations
The current study has all the inherent limitations associated with nonrandomized, single-site, observational studies. Although the impact of selection biases, spurious observations, and missing data cannot be ignored, patients in observational studies better represent those seen in practice compared with those in randomized trials. The current study was designed as an effectiveness study in that post-CMR patient management was dictated by their physicians' clinical practice. A single reader (S.E.B.) interpreted all CMR studies, and no consensus interpretation was performed. However, our group has previously shown that intraobserver variability was minimal. 22 Finally, it would be difficult to state to what extent the current results are generalizable to studies using dobutamine stress CMR, an alternative form of stress CMR.
Several statistical issues are also relevant. First, survival analyses indicated that the added value of CMR variables often did not manifest a dramatic increase in global Wald 2 . It is important to note that, despite this, the risk-adjusted HR associated with the CMR covariates in this setting were quite large. For example, the addition of DE information to the survival model increased the 2 from 57.5 to 63.5. Although this is not a dramatic gain, the HR associated with DE (2.10) indicates a doubling of risk in the presence of this CMR finding, even after adjusting for other factors. Thus, although the change in 2 was not large, the clinical impact was significant. In order to avoid overfitting our models, total cardiac events was the primary analytic end point of the second analysis. A larger study population or a higher incidence of adverse events would be required to overcome this limitation. Importantly, when using a composite end point, the interpretation of the results should be made in the context of what type of event was predominant in the study. 12 
Conclusions
Consideration of all components of stress perfusion CMR enhances posttest risk stratification. These parameters are incremental to pre-CMR data and to each other. Further studies to define how these parameters may be best applied will be needed. 
CLINICAL PERSPECTIVE
Cardiac magnetic resonance imaging (CMR) is unique in its ability to provide assessment of hemodynamics, ventricular structure and function, valvular structure and function, myocardial viability, and stress perfusion. Various CMR-derived data are known to provide important prognostic information. However, the relative incremental prognostic value of 4 CMR components (vasodilator stress perfusion, myocardial delayed enhancement, aortic blood flow, and left ventricular volumes) is unclear. We followed up 908 patients for a mean of 2.6Ϯ1.2 years after they underwent combined 4-component CMR for suspicion of coronary stenosis and/or ischemia. In total, 101 cardiac events were observed, including 30 cardiac deaths, 36 noncardiac deaths, 5 nonfatal myocardial infarctions, and 19 late revascularizations. Normal 4-component CMR was followed by a 2.4% annual cardiac event rate (Ͻ0.4% for cardiac death) whereas abnormal CMR had an event rate of 5.6% to 7.0%. The risk of cardiac events increased significantly with increasing number of abnormal CMR components. After we adjusted for pre-CMR data, the addition of left ventricular ejection fraction, aortic flow, delayed enhancement, and stress perfusion data all added incremental prognostic power. CMR components were additive, not redundant, in predicting risk. Future studies may define how each CMR component is best applied in clinical practice.
